{
  "ptid_time": "031_S_4203_2011-08-31",
  "img_path": "/data/qiuhui/data/adni/images/031_S_4203/2011-08-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 60,070 mm³, 114.0% above the reference mean. With a Z-score of 2.61 (99.5th percentile), this represents significant enlargement; hippocampal volume measures 5,715 mm³, 19.7% below the reference mean. With a Z-score of -1.80 (3.6th percentile), this represents moderate atrophy; whole brain volume measures 914,574 mm³, 6.2% below the reference mean. With a Z-score of -0.78 (21.9th percentile), this represents normal volume ; entorhinal cortex volume measures 1,497 mm³, 59.2% below the reference mean. With a Z-score of -3.64 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 14,056 mm³, 17.4% below the reference mean. With a Z-score of -1.58 (5.7th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 17,266 mm³, 9.9% below the reference mean. With a Z-score of -0.86 (19.4th percentile), this represents normal volume . ",
  "text_data": "Age is 74.4 years. Gender is Female. Education: 17 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Major Surgical Procedures. MMSE: 30.0. MoCA: 25.0. Logical Memory: 2.0. Laboratory findings: Neutrophils: 77.80 (significant elevated); WBC: 9.45 (significant elevated); Neutrophils: 7.35 (profound elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.29 SUVR (moderate elevated); Amyloid beta: 949.00 pg/mL (normal ); Total tau: 241.60 pg/mL (normal ); Phosphorylated tau: 22.56 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant ventricular enlargement (114% above mean) and profound entorhinal cortex atrophy (59.2% below mean, Z-score -3.64), both strongly associated with Alzheimer's pathology. Hippocampal and fusiform gyrus atrophy further support neurodegeneration. Despite normal Aβ and tau biomarkers, the AV45 PET (moderate elevated) suggests amyloid deposition. The MMSE is normal (30), but the MoCA (25) indicates subtle cognitive impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, neurodegenerative subtype).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but biomarker discordance—normal CSF Aβ/tau vs. elevated AV45—warrants caution).  \n\n*Note:* Progression to dementia is likely given the severity of entorhinal/hippocampal atrophy, but current cognitive scores don't meet dementia thresholds. Follow-up clinical correlation is key.",
  "timestamp": "2025-07-26T04:47:51.639183"
}